Detalles de la búsqueda
1.
Long-term outcomes of radical prostatectomy versus low-dose-rate brachytherapy in patients with intermediate-risk prostate cancer: Propensity score matched comparison.
Prostate
; 83(2): 135-141, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36176043
2.
Do we need repeat transurethral resection after en bloc resection for pathological T1 bladder cancer?
BJU Int
; 131(2): 190-197, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35488409
3.
Iatrogenic ureteric injury during abdominal or pelvic surgery: a meta-analysis.
BJU Int
; 131(5): 540-552, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36196670
4.
Re-challenging chemotherapy after pembrolizumab in platinum-refractory urothelial carcinoma.
BJU Int
; 131(4): 477-485, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36098556
5.
Combination of docetaxel versus nonsteroidal antiandrogen with androgen deprivation therapy for high-volume metastatic hormone-sensitive prostate cancer: a propensity score-matched analysis.
World J Urol
; 41(8): 2051-2062, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-35596809
6.
Impact of sex on outcomes after surgery for non-muscle-invasive and muscle-invasive bladder urothelial carcinoma: a systematic review and meta-analysis.
World J Urol
; 41(4): 909-919, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35963957
7.
Effect of upfront intensive therapy on oncological outcomes in older patients with high tumor burden metastatic castration-sensitive prostate cancer: A multicenter retrospective study.
Prostate
; 82(13): 1304-1312, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35747992
8.
Clinical significance of unfavorable findings in intermediate-risk prostate cancer patients for predicting treatment outcomes after contemporary, dose-escalated multimodal radiotherapy.
Prostate
; 82(4): 433-441, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34914134
9.
Does castration status affect docetaxel-related adverse events? :Identification of risk factors for docetaxel-related adverse events in metastatic prostate cancer.
Prostate
; 82(14): 1322-1330, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35767376
10.
Abiraterone acetate versus nonsteroidal antiandrogen with androgen deprivation therapy for high-risk metastatic hormone-sensitive prostate cancer.
Prostate
; 82(1): 3-12, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34559410
11.
Clinical benefit of continuing pembrolizumab treatment beyond progression in patients with metastatic urothelial carcinoma.
Cancer Immunol Immunother
; 71(1): 229-236, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34100985
12.
En Bloc Resection for Bladder Tumors: An Updated Systematic Review and Meta-Analysis of Its Differential Effect on Safety, Recurrence and Histopathology.
J Urol
; 207(4): 754-768, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35060770
13.
Prognostic Role of Preoperative Vascular Cell Adhesion Molecule-1 Plasma Levels in Urothelial Carcinoma of the Bladder Treated With Radical Cystectomy.
Ann Surg Oncol
; 29(8): 5307-5316, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-35347517
14.
Systemic therapies for metastatic hormone-sensitive prostate cancer: network meta-analysis.
BJU Int
; 129(4): 423-433, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34171173
15.
Real-world survival outcomes of adding docetaxel or abiraterone in patients with high-volume metastatic castration-sensitive prostate cancer: historically controlled, propensity score matched comparison with androgen deprivation therapy.
World J Urol
; 40(5): 1135-1141, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-35218371
16.
Effects of human Muse cells on bladder inflammation, overactivity, and nociception in a chemically induced Hunner-type interstitial cystitis-like rat model.
Int Urogynecol J
; 33(5): 1293-1301, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35333929
17.
Enzalutamide in patients with non-metastatic castration-resistant prostate cancer after combined androgen blockade for recurrence following radical treatment in Japan (Japanese research for patients with non-metastatic castration-resistant prostate cancer-enzalutamide: JCASTRE-zero)-a prospective single-arm interventional study.
BMC Urol
; 22(1): 151, 2022 Sep 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-36104667
18.
Nationwide surveillance of the antimicrobial susceptibility of Chlamydia trachomatis from male urethritis in Japan: Comparison with the first surveillance report.
J Infect Chemother
; 28(1): 1-5, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34580009
19.
The prognostic value of the preoperative lung immune prognostic index in patients with urothelial bladder cancer undergoing radical cystectomy.
Int J Clin Oncol
; 27(2): 396-402, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-34714458
20.
Prognostic value of PSA bounce after definitive radiotherapy revisited.
Int J Clin Oncol
; 27(2): 411-417, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-34677737